adenosine and nitd008
adenosine has been researched along with nitd008 in 13 studies
Research
Studies (13)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (92.31) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Alonso, S; Deng, CL; Gong, P; Liu, SQ; Shang, BD; Shi, PY; Ye, HQ; Yeo, H; Zhang, B | 1 |
| Cao, L; Gong, P; Lou, Z; Qing, J; Shang, L; Shu, B; Sun, Y; Wang, Y; Yin, Z | 1 |
| Nelson, J; Orillo, B; Roe, K; Shi, PY; Verma, S | 1 |
| Luo, R; Nong, J; Qing, J; Shao, Y; Sun, Y; Tang, R; Wang, Y; Wu, M; Yin, Z; Yu, X | 1 |
| Chen, YL; Flint, M; Lo, MK; Shi, PY; Spiropoulou, CF | 1 |
| Behera, I; Beigelman, L; Chaudhuri, S; Deval, J; Dyatkina, N; Jekle, A; Jin, Z; Kinkade, A; Rajwanshi, VK; Smith, DB; Symons, JA; Tucker, K; Wang, G | 1 |
| Chen, DD; Deng, CL; Liu, SQ; Qin, CF; Ye, HQ; Zhang, B; Zhang, QY | 1 |
| Ncube, NB; Ramharack, P; Soliman, MES | 1 |
| Boura, E; Dubankova, A; Nencka, R; Ruzek, D; Šebera, J; Sychrovský, V | 1 |
| Enosi Tuipulotu, D; Mackenzie, JM; Netzler, NE; Vasudevan, SG; White, PA | 1 |
| Chan, KWK; Tan, NWW; Vasudevan, SG; Watanabe, S | 1 |
| Enosi Tuipulotu, D; Fumian, TM; Mackenzie, JM; Netzler, NE; White, PA | 1 |
| Cao, R; Fan, S; Li, S; Li, W; Li, X; Li, Y; Yan, L; Zhang, H; Zhong, W | 1 |
Other Studies
13 other study(ies) available for adenosine and nitd008
| Article | Year |
|---|---|
Inhibition of enterovirus 71 by adenosine analog NITD008.
Topics: Adenosine; Animals; Antiviral Agents; Chlorocebus aethiops; Drug Resistance, Viral; Enterovirus A, Human; Enterovirus Infections; Mice; Mutation; Vero Cells; Viral Load; Viral Plaque Assay; Virus Replication | 2014 |
An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation.
Topics: Adenosine; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Drug Synergism; Enterovirus A, Human; Humans; Isoxazoles; Phenylalanine; Pyrrolidinones; RNA-Dependent RNA Polymerase; Valine; Virus Replication | 2014 |
Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection.
Topics: Adenosine; Animals; Brain; Chemokine CCL3; Chlorocebus aethiops; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Hydroxamic Acids; Mice; Tumor Necrosis Factor-alpha; Vero Cells; Virus Replication; Vorinostat; West Nile Fever; West Nile virus | 2015 |
Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.
Topics: Adenosine; Antiviral Agents; Cell Line; Drug Resistance, Viral; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Mutation; Oligopeptides; Protease Inhibitors; Replicon; Ribavirin; RNA, Viral; Sofosbuvir; Viral Nonstructural Proteins; Virus Replication | 2016 |
In vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses.
Topics: Adenosine; Antiviral Agents; Cell Line; Cells, Cultured; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Flavivirus; Flavivirus Infections; Humans; Tick-Borne Diseases; Virus Replication | 2016 |
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs.
Topics: Adenosine; Amides; Antiviral Agents; Cell Line; Cytidine; DNA-Directed RNA Polymerases; Guanosine Monophosphate; Humans; Inhibitory Concentration 50; Mitochondria; Mitochondrial Proteins; Nucleosides; Prodrugs; Protein Biosynthesis; Pyrazines; Ribonucleosides; RNA; RNA, Mitochondrial; Sofosbuvir; Structure-Activity Relationship; Transcription Initiation Site; Transcription, Genetic | 2017 |
Recovery of the Zika virus through an in vitro ligation approach.
Topics: Adenosine; Aedes; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cloning, Molecular; Cricetinae; Deoxyribonucleases, Type II Site-Specific; DNA, Complementary; DNA, Viral; Genome, Viral; RNA, Viral; Vero Cells; Zika Virus | 2017 |
An "All-In-One" Pharmacophoric Architecture for the Discovery of Potential Broad-Spectrum Anti-Flavivirus Drugs.
Topics: Adenosine; Antiviral Agents; Catalytic Domain; Drug Discovery; Flaviviridae; Models, Chemical; Molecular Docking Simulation; Molecular Dynamics Simulation; RNA-Dependent RNA Polymerase; Thermodynamics; Virus Replication | 2018 |
The structural model of Zika virus RNA-dependent RNA polymerase in complex with RNA for rational design of novel nucleotide inhibitors.
Topics: Adenosine; Humans; Magnesium; Models, Molecular; Molecular Docking Simulation; Nucleosides; Nucleotides; Polyphosphates; Protein Conformation; RNA; RNA-Dependent RNA Polymerase; Viral Nonstructural Proteins; Virus Replication; Zika Virus; Zika Virus Infection | 2018 |
Antiviral Candidates for Treating Hepatitis E Virus Infection.
Topics: Adenosine; Antiviral Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Genes, Reporter; Hepatitis E; Hepatitis E virus; Humans; Nitriles; Nitro Compounds; Replicon; RNA, Viral | 2019 |
Assessing the utility of antivirals for preventing maternal-fetal transmission of zika virus in pregnant mice.
Topics: Adenosine; Animals; Antiviral Agents; Disease Models, Animal; Female; Fetus; Humans; Infectious Disease Transmission, Vertical; Mice; Microcephaly; Nervous System Malformations; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zika Virus; Zika Virus Infection | 2019 |
The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses.
Topics: Adenosine; Animals; Antiviral Agents; Caliciviridae Infections; Calicivirus, Feline; Cats; Humans; Norovirus; Nucleosides; Virus Replication | 2019 |
Design, synthesis and evaluation of 2'-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents.
Topics: Adenosine; Antiviral Agents; Dose-Response Relationship, Drug; Drug Design; Enterovirus; Enterovirus Infections; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |